Share ownership Sun Pharmaceutical Industries Ltd.

SUNPHARMA

INE044A01036

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 04:44:40 2026-01-20 am EST			5-day change	1st Jan Change
1,611.20 ^INR	-3.83%		-7.24%	-6.36%

Jan. 19	Sun Pharma states Organon acquisition news is speculative	RE
Jan. 15	Sun Pharmaceutical Industries Limited Announces the Availability of UNLOXCYT (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma	CI

Share class: Sun Pharmaceutical Industries Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,399,334,970	1,077,377,054 ( 44.9 %)	0	44.9 %

Major shareholders: Sun Pharmaceutical Industries Ltd.

Name	Equities	%	Valuation
Shanghvi Finance Pvt Ltd. 41.98 %	1,007,205,692	41.98 %	19 272 M ₹
Dilip Shantilal Shanghvi 9.602 %	230,385,155	9.602 %	4 408 M ₹
LIFE INSURANCE CORPORATION OF INDIA 5.005 %	120,079,148	5.005 %	2 298 M ₹
SBI Funds Management Ltd. 1.79 %	42,953,433	1.79 %	822 M ₹
Raksha Sudhir Valia 1.202 %	28,830,352	1.202 %	552 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt) 1.089 %	26,136,858	1.089 %	500 M ₹
Lakshdeep Investments & Finance Pvt Ltd. 1.018 %	24,418,497	1.018 %	467 M ₹
SBI Life Insurance Co. Ltd. (Investment Portfolio) 0.9775 %	23,452,936	0.9775 %	449 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt) 0.7727 %	18,539,685	0.7727 %	355 M ₹
UTI Asset Management Co. Ltd. (Investment Management) 0.7721 %	18,523,868	0.7721 %	354 M ₹
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Other	43.43%
Individuals	12.07%
Institutional	11.73%
Life Insurance Corporation of India	5%
Governments	0.12%
Unknown	27.64%

Based on 1000 largest holdings

Geographical origin of shareholders

India	58.88%
Individuals	12.07%
United Kingdom	0.8%
Singapore	0.24%
Sweden	0.12%
Norway	0.05%
Ireland	0.05%
Hong Kong	0.05%
Denmark	0.02%
Switzerland	0.01%
Netherlands	0.01%
Luxembourg	0.01%
Japan	0.01%
China	0.01%
United States	0.01%
Finland	0.01%
France	0.01%

Based on 1000 largest holdings

Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).

Employees

43,000

Sector

Pharmaceuticals

Calendar

Feb. 03 - Q3 2026 Earnings Release (Projected)

More about the company